As a surgeon who has performed more than 7000 thyroidectomies throughout 4 decades, I have witnessed a significant amount of change. When I started, the premise of surgery for a suspicious mass was based on very little evidence; too many total thyroidectomies were performed, and too much postoperative radioactive iodine was administered. In this Viewpoint, I discuss the significant changes in the treatment of patients with thyroid cancer throughout the last 4 decades.
Over the years, indications for surgery within my practice have changed with an increase in the number of cases performed for biopsy-proven cancer and a decrease in the number performed for clinical/cytological suspicion of cancer and benign disease with risk factors. It is these indications that bear further discussion.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Freeman JL. Surgical Management of Thyroid Nodular Disease—Personal Evolution Throughout 4 Decades of Practice. JAMA Otolaryngol Head Neck Surg. 2020;146(3):223–224. doi:10.1001/jamaoto.2019.4471
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: